Literature DB >> 22391204

Rad18 is a transcriptional target of E2F3.

Lakshman Varanasi1, Phi M Do, Elzbieta Goluszko, Luis A Martinez.   

Abstract

The E2F family of transcription factors responds to a variety of intracellular and extracellular signals and, as such, are key regulators of cell growth, differentiation and cell death. The cellular response to DNA damage is a multistep process generally involving the initial detection of DNA damage, propagation of signals via posttranslational modifications (e.g., phosphorylation and ubiquitination) and, finally, the implementation of a response. We have previously reported that E2F3 can be induced by DNA damage, and that it plays an important role in DNA damage-induced apoptosis. Here, we demonstrate that E2F3 knockdown compromises two canonical DNA damage modification events, the ubiquitination of H2AX and PCNA. We find that the defect in these posttranscriptional modifications after E2F3 knockdown is due to reduced expression of important DNA damage responsive ubiquitin ligases. We characterized the regulation of one of these ligases, Rad18, and we demonstrated that E2F3 associates with the Rad18 promoter and directly controls its activity. Furthermore, we find that ectopic expression of Rad18 is sufficient to rescue the PCNA ubiquitination defect resulting from E2F3 knockdown. Our study reveals a novel facet of E2F3's control of the DNA damage response.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22391204     DOI: 10.4161/cc.11.6.19558

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  4 in total

1.  High RAD18 Expression is Associated with Disease Progression and Poor Prognosis in Patients with Gastric Cancer.

Authors:  Seded Baatar; Tuya Bai; Takehiko Yokobori; Navchaa Gombodorj; Nobuhiro Nakazawa; Yasunari Ubukata; Akiharu Kimura; Norimichi Kogure; Akihiko Sano; Makoto Sohda; Makoto Sakai; Amartuvshin Tumenjargal; Kyoichi Ogata; Hiroyuki Kuwano; Ken Shirabe; Hiroshi Saeki
Journal:  Ann Surg Oncol       Date:  2020-04-30       Impact factor: 5.344

2.  The Rad6/18 ubiquitin complex interacts with the Epstein-Barr virus deubiquitinating enzyme, BPLF1, and contributes to virus infectivity.

Authors:  Ravindra Kumar; Christopher B Whitehurst; Joseph S Pagano
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

Review 3.  Regulation of Rad6/Rad18 Activity During DNA Damage Tolerance.

Authors:  Mark Hedglin; Stephen J Benkovic
Journal:  Annu Rev Biophys       Date:  2015       Impact factor: 12.981

4.  Class I HDAC overexpression promotes temozolomide resistance in glioma cells by regulating RAD18 expression.

Authors:  Daniela Hanisch; Andrea Krumm; Tamara Diehl; Carla M Stork; Mario Dejung; Falk Butter; Ella Kim; Walburgis Brenner; Gerhard Fritz; Thomas G Hofmann; Wynand P Roos
Journal:  Cell Death Dis       Date:  2022-04-01       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.